Creative Planning’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
|
|||||
|
2025
Q1 | $1.84M | Sell |
|
|||||
|
2024
Q4 | $2.22M | Buy |
|
|||||
|
2024
Q3 | $1.01M | Buy |
|
|||||
|
2024
Q2 | $974K | Buy |
|
|||||
|
2024
Q1 | $987K | Sell |
|
|||||
|
2023
Q4 | $1.09M | Buy |
|
|||||
|
2023
Q3 | $758K | Buy |
|
|||||
|
2023
Q2 | $699K | Buy |
|
|||||
|
2023
Q1 | $679K | Buy |
|
|||||
|
2022
Q4 | $706K | Buy |
|
|||||
|
2022
Q3 | $533K | Buy |
|
|||||
|
2022
Q2 | $517K | Buy |
|
|||||
|
2022
Q1 | $269K | Sell |
|
|||||
|
2021
Q4 | $424K | Buy |
|
|||||
|
2021
Q3 | $369K | Buy |
|
|||||
|
2021
Q2 | $377K | Sell |
|
|||||
|
2021
Q1 | $375K | Sell |
|
|||||
|
2020
Q4 | $487K | Sell |
|
|||||
|
2020
Q3 | $467K | Buy |
|
|||||
|
2020
Q2 | $631K | Sell |
|
|||||
|
2020
Q1 | $501K | Sell |
|
|||||
|
2019
Q4 | $820K | Sell |
|
|||||
|
2019
Q3 | $660K | Buy |
|
|||||
|
2019
Q2 | $828K | Sell |
|
|||||
|
2019
Q1 | $1.32M | Sell |
|
|||||
|
2018
Q4 | $1.54M | Buy |
|
|||||
|
2018
Q3 | $450K | Sell |
|
|||||
|
2018
Q2 | $485K | Sell |
|
|||||
|
2018
Q1 | $428K | Sell |
|
|||||
|
2017
Q4 | $552K | Buy |
|
|||||
|
2017
Q3 | $378K | Buy |
|
|||||
|
2017
Q2 | $295K | Sell |
|
|||||
|
2017
Q1 | $1.18M | Buy |
|
|||||
|
2016
Q4 | $1.1M | Sell |
|
|||||
|
2016
Q3 | $1.27M | Buy |
|
|||||
|
2016
Q2 | $278K | Buy |
|
|||||
|
2016
Q1 | $227K | Buy |
|
|||||
|
2015
Q4 | $286K | Buy |
|
|||||
|
2015
Q3 | $252K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $221K | Sell |
|
|||||
|
2014
Q4 | $1.01M | Buy |
|
|||||
|
2014
Q3 | $270K | Sell |
|
|||||
|
2014
Q2 | $468K | Buy |
|
|||||
|
2014
Q1 | $242K | Buy |
|
|||||
|
2013
Q4 | $117K | Sell |
|
|||||
|
2013
Q3 | $130K | Sell |
|
|||||
|
2013
Q2 | $738K | Buy |
|